These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
329 related articles for article (PubMed ID: 15907982)
1. In vitro model of normal, immortalized ovarian surface epithelial and ovarian cancer cells for chemoprevention of ovarian cancer. Brewer M; Wharton JT; Wang J; McWatters A; Auersperg N; Gershenson D; Bast R; Zou C Gynecol Oncol; 2005 Aug; 98(2):182-92. PubMed ID: 15907982 [TBL] [Abstract][Full Text] [Related]
2. Analysis of gene expression identifies PLAB as a mediator of the apoptotic activity of fenretinide in human ovarian cancer cells. Appierto V; Villani MG; Cavadini E; Gariboldi M; De Cecco L; Pierotti MA; Lambert JR; Reid J; Tiberio P; Colombo N; Formelli F Oncogene; 2007 Jun; 26(27):3952-62. PubMed ID: 17213814 [TBL] [Abstract][Full Text] [Related]
3. 4-oxo-fenretinide, a recently identified fenretinide metabolite, induces marked G2-M cell cycle arrest and apoptosis in fenretinide-sensitive and fenretinide-resistant cell lines. Villani MG; Appierto V; Cavadini E; Bettiga A; Prinetti A; Clagett-Dame M; Curley RW; Formelli F Cancer Res; 2006 Mar; 66(6):3238-47. PubMed ID: 16540676 [TBL] [Abstract][Full Text] [Related]
4. Comparison of the mechanism of induction of apoptosis in ovarian carcinoma cells by the conformationally restricted synthetic retinoids CD437 and 4-HPR. Holmes WF; Soprano DR; Soprano KJ J Cell Biochem; 2003 May; 89(2):262-78. PubMed ID: 12704790 [TBL] [Abstract][Full Text] [Related]
5. The chemopreventive agent N-(4-hydroxyphenyl)retinamide induces apoptosis through a mitochondrial pathway regulated by proteins from the Bcl-2 family. Boya P; Morales MC; Gonzalez-Polo RA; Andreau K; Gourdier I; Perfettini JL; Larochette N; Deniaud A; Baran-Marszak F; Fagard R; Feuillard J; Asumendi A; Raphael M; Pau B; Brenner C; Kroemer G Oncogene; 2003 Sep; 22(40):6220-30. PubMed ID: 13679861 [TBL] [Abstract][Full Text] [Related]
6. A phase I-II preoperative biomarker trial of fenretinide in ascitic ovarian cancer. Colombo N; Formelli F; Cantù MG; Parma G; Gasco M; Argusti A; Santinelli A; Montironi R; Cavadini E; Baglietto L; Guerrieri-Gonzaga A; Viale G; Decensi A Cancer Epidemiol Biomarkers Prev; 2006 Oct; 15(10):1914-9. PubMed ID: 17035399 [TBL] [Abstract][Full Text] [Related]
8. Hypoxia-mediated fenretinide (4-HPR) resistance in childhood acute lymphoblastic leukemia cells. Yang B; Fan L; Fang L; He Q Cancer Chemother Pharmacol; 2006 Oct; 58(4):540-6. PubMed ID: 16520989 [TBL] [Abstract][Full Text] [Related]
9. Mechanism of synergy of N-(4-hydroxyphenyl)retinamide and ABT-737 in acute lymphoblastic leukemia cell lines: Mcl-1 inactivation. Kang MH; Wan Z; Kang YH; Sposto R; Reynolds CP J Natl Cancer Inst; 2008 Apr; 100(8):580-95. PubMed ID: 18398104 [TBL] [Abstract][Full Text] [Related]
10. N-(4-Hydroxyphenyl)retinamide and nitric oxide pro-drugs exhibit apoptotic and anti-invasive effects against bone metastatic breast cancer cells. Simeone AM; Colella S; Krahe R; Johnson MM; Mora E; Tari AM Carcinogenesis; 2006 Mar; 27(3):568-77. PubMed ID: 16199439 [TBL] [Abstract][Full Text] [Related]
11. Differential effects of N-(4-hydroxyphenyl)retinamide and retinoic acid on neuroblastoma cells: apoptosis versus differentiation. Ponzoni M; Bocca P; Chiesa V; Decensi A; Pistoia V; Raffaghello L; Rozzo C; Montaldo PG Cancer Res; 1995 Feb; 55(4):853-61. PubMed ID: 7850799 [TBL] [Abstract][Full Text] [Related]
12. N-(4-hydroxyphenyl)retinamide induces apoptosis of malignant hemopoietic cell lines including those unresponsive to retinoic acid. Delia D; Aiello A; Lombardi L; Pelicci PG; Grignani F; Grignani F; Formelli F; Menard S; Costa A; Veronesi U Cancer Res; 1993 Dec; 53(24):6036-41. PubMed ID: 8261419 [TBL] [Abstract][Full Text] [Related]
13. The synthetic retinoid CD437 selectively induces apoptosis in human lung cancer cells while sparing normal human lung epithelial cells. Sun SY; Yue P; Chen X; Hong WK; Lotan R Cancer Res; 2002 Apr; 62(8):2430-6. PubMed ID: 11956107 [TBL] [Abstract][Full Text] [Related]
14. Effect of 4-hydroxyphenylretinamide on human cervical epithelial and cancer cell lines. Zou C; Vlastos AT; Yang Li; Wang J; Brewer M; Follen M J Soc Gynecol Investig; 2003 Jan; 10(1):41-8. PubMed ID: 12517593 [TBL] [Abstract][Full Text] [Related]
15. Progesterone-induced apoptosis in immortalized normal and malignant human ovarian surface epithelial cells involves enhanced expression of FasL. Syed V; Ho SM Oncogene; 2003 Oct; 22(44):6883-90. PubMed ID: 14534535 [TBL] [Abstract][Full Text] [Related]
16. 4-HPR modulates gene expression in ovarian cells. Brewer M; Kirkpatrick ND; Wharton JT; Wang J; Hatch K; Auersperg N; Utzinger U; Gershenson D; Bast R; Zou C Int J Cancer; 2006 Sep; 119(5):1005-13. PubMed ID: 16570282 [TBL] [Abstract][Full Text] [Related]
18. BAG-1 promotes apoptosis induced by N-(4-hydroxyphenyl)retinamide in human cervical carcinoma cells. Yang X; Hao Y; Ding Z; Pater A Exp Cell Res; 2000 May; 256(2):491-9. PubMed ID: 10772821 [TBL] [Abstract][Full Text] [Related]
19. Synergistic effects of the fenretinide (4-HPR) and anti-CD20 monoclonal antibodies on apoptosis induction of malignant human B cells. Shan D; Gopal AK; Press OW Clin Cancer Res; 2001 Aug; 7(8):2490-5. PubMed ID: 11489831 [TBL] [Abstract][Full Text] [Related]